Triune Financial Partners LLC Acquires New Position in Danaher Co. (NYSE:DHR)

Triune Financial Partners LLC purchased a new stake in shares of Danaher Co. (NYSE:DHR) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,169 shares of the conglomerate’s stock, valued at approximately $325,000. Danaher makes up about 0.1% of Triune Financial Partners LLC’s investment portfolio, making the stock its 24th biggest position.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. nVerses Capital LLC bought a new stake in shares of Danaher in the 2nd quarter valued at approximately $25,000. CarsonAllaria Wealth Management Ltd. purchased a new position in Danaher during the second quarter worth $25,000. MFA Wealth Advisors LLC purchased a new position in Danaher during the second quarter worth $51,000. Financial Connections Group Inc. bought a new position in Danaher during the second quarter valued at $51,000. Finally, Western Pacific Wealth Management LP purchased a new stake in shares of Danaher in the first quarter valued at $55,000. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. StockNews.com raised Danaher from a “hold” rating to a “buy” rating in a research report on Wednesday. UBS Group cut their price target on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target for the company in a research report on Thursday, October 31st. Wells Fargo & Company assumed coverage on shares of Danaher in a report on Tuesday, August 27th. They issued an “equal weight” rating and a $280.00 price objective on the stock. Finally, Stephens reiterated an “overweight” rating and set a $315.00 price objective on shares of Danaher in a research note on Wednesday, October 23rd. Five investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $287.16.

Insider Transactions at Danaher

In other Danaher news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 10.90% of the company’s stock.

Danaher Stock Performance

Shares of NYSE DHR traded down $0.09 during mid-day trading on Friday, hitting $246.01. 720,843 shares of the company were exchanged, compared to its average volume of 2,733,857. The firm has a market cap of $177.69 billion, a price-to-earnings ratio of 46.97, a price-to-earnings-growth ratio of 4.54 and a beta of 0.85. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $192.35 and a 1-year high of $281.70. The stock has a 50 day simple moving average of $265.79 and a 200-day simple moving average of $260.75.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating the consensus estimate of $1.57 by $0.14. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.02 EPS. On average, sell-side analysts forecast that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date was Friday, September 27th. This represents a $1.08 annualized dividend and a yield of 0.44%. Danaher’s dividend payout ratio (DPR) is presently 20.61%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.